IGF2 OVEREXPRESSION Detail (hg19) (IGF2)

Information

Genome

Assembly Position
hg19 chr11:2,150,348-2,170,833
hg38 chr11:2,129,118-2,149,603 View the variant detail on this assembly version.
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM
HGNC
Ensembl
NCBI
Gene Cards
OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
prostate cancer Linsitinib D Predictive Supports N/A Somatic 3 25670080 Detail
prostate cancer Cabazitaxel,Docetaxel,Linsitinib D Predictive Supports Sensitivity/Response Somatic 3 25670080 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
OSI-906, an IGF1R/INSR inhibitor, does not have a significant effect on chemotherapy resistant castr... CIViC Evidence Detail
OSI-906, an IGF1R/INSR inhibitor, sensitizes cell lines to docetaxel and cabazitaxel, resulting in b... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr11:2,150,348-2,170,833
Variant Type
cnv
Variant (CIViC) (CIViC Variant)
OVEREXPRESSION
Transcript 1 (CIViC Variant)
ENST00000300632.5
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/156
Genome browser